Edition:
United States

Profile: Bioanalytical Systems Inc (BASI.O)

BASI.O on Consolidated Issue listed on NASDAQ Capital Market

1.58USD
23 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.58
Open
$1.58
Day's High
$1.64
Day's Low
$1.57
Volume
7,320
Avg. Vol
331,460
52-wk High
$2.42
52-wk Low
$0.60

Bioanalytical systems, Inc., incorporated on July 17, 1975, is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates.

Contract Research Services

The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The product characterization, method development and validation service uses analytical methods to determine potency, purity, chemical composition, structure and physical properties of a compound. The Bioanalytical Testing service of the Company analyzes specimens from preclinical and clinical trials to measure drug and metabolite concentrations in complex biological matrices. The Stability Testing service tests stability of drug substances and formulated drug products, and maintains secure storage facilities in Indiana to establish and confirm product purity, potency and shelf life. In Vivo Pharmacology, the Company provides preclinical in vivo sampling services for the continuous monitoring of chemical changes in life, in particular, how a drug enters, travels through, and is metabolized in living systems. The Preclinical and Pathology Services provide pharmacokinetic and safety testing in studies ranging from safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity studies in its Evansville, Indiana site.

Research Products

The Company's products business focuses on expediting preclinical screening of developmental drugs. The Company design, develop, manufacture in vivo sampling systems and accessories (including disposables, training and systems qualification), physiology monitoring tools, and liquid chromatography and electrochemistry instruments platforms. The Analytical product comprises liquid chromatographic and electrochemical instruments with associated accessories. The primary component of these products is the Epsilon electrochemical platform. This platform incorporates all the hardware capabilities needed for electrochemical experiments but can be modified through software development. Its in vivo sampling product comprises the Culex family of automated in vivo sampling and dosing instruments. These instruments are used by pharmaceutical researchers to dose animals and collect biological samples (blood, bile, urine, microdialysate, feces or any bio-fluid) from the animals. The Vetronics' Products comprises instruments and related software to monitor and diagnose cardiac function (electro-cardiogram) and measure other physiological parameters in cats and dogs in veterinary clinics.

The Company competes with LabCorp, Pharmaceutical Product Development, Inc., Charles River Laboratories, Inc. and Quintiles Transnational Holdings, Inc.

Company Address

Bioanalytical Systems Inc

2701 Kent Ave
WEST LAFAYETTE   IN   47906-1350
P: +1317.4634527
F: +1765.4971102

Company Web Links